HighTower Advisors
CRVO icon

HighTower Advisors’s CervoMed CRVO Stock Holding History

HighTower Advisors’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.9K Buy
11,919
+654
+6% +$2.3K ﹤0.01% 3743
2026
Q1 		$44.4K Buy
11,265
+21
+0.2% +$110 ﹤0.01% 3715
2025
Q4 		$88.8K Hold
11,244
– – ﹤0.01% 3524
2025
Q3 		$91K Hold
11,244
– – ﹤0.01% 3555
2025
Q2 		$70.7K Sell
11,244
-100
-0.9% -$852 ﹤0.01% 3521
2025
Q1 		$104K Buy
+11,344
New +$43.2K ﹤0.01% 3349

Other funds holding CRVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $774M AUM 27.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

HighTower Advisors's CRVO Position: Q2 2026 in Review

HighTower Advisors increased its CervoMed (CRVO) stake by 5.8% in Q2 2026, buying an estimated $2.3K and bringing the position to 11,919 shares worth $36.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3743.

HighTower Advisors first reported a position in CRVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $104K in Q1 2025. 13 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • HighTower Advisors held 11,919 shares of CervoMed worth $36.9K as of Q2 2026.
  • HighTower Advisors bought 654 CervoMed shares in Q2 2026, an estimated $2.3K.
  • CervoMed made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3743 holding.
  • HighTower Advisors first reported a position in CervoMed in Q1 2025 and has held it in 6 quarters since.
  • HighTower Advisors's CervoMed position peaked at $104K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.